, are transforming how carotid disease is treated and complement the Medtronic peripheral and stroke protection portfolio,' said David Moeller, senior vice president and president of Medtronic Peripheral Vascular Health, which is part of the company’s Cardiovascular portfolio. 'This strategic agreement with Contego Medical expands our commitment to this fast-growing carotid market and exemplifies Medtronic’s steadfast dedication to advancing innovation and enhancing patient care.”.

美敦力外周血管健康公司（Medtronic peripheral Vascular Health）的高级副总裁兼总裁大卫·穆勒（David Moeller）说，他们正在改变颈动脉疾病的治疗方式，并补充美敦力外周和中风保护产品组合与Contego Medical达成的这项战略协议扩大了我们对这一快速增长的颈动脉市场的承诺，并体现了美敦力对推进创新和加强患者护理的坚定承诺。”。

This agreement includes Contego Medical’s portfolio of commercially available products, including the recently FDA approved Neuroguard IEP® System, a unique 3-in-1 carotid stenting system that combines a high-performance

该协议包括Contego Medical的商业产品组合，包括最近FDA批准的Neuroguard IEP®系统，这是一种独特的三合一颈动脉支架系统，结合了高性能

stent, post-dilation balloon, and an integrated embolic protection (IEP) filter as well as Excipio® Peripheral Thrombectomy Devices.

支架，扩张后球囊，集成栓塞保护（IEP）过滤器以及Excipio®外周血栓切除装置。

The Neuroguard IEP system is backed by clinical data demonstrating the safety and effectiveness of the system. Contego reports the PERFORMANCE I Trial and PERFORMANCE II IDE Trial consistently recorded unprecedented low event rates – zero major strokes, zero neurologic deaths, and zero stent thromboses up to 2-year follow-up..

Neuroguard IEP系统得到了临床数据的支持，证明了该系统的安全性和有效性。Contego报告说，PERFORMANCE I试验和PERFORMANCE II IDE试验始终记录了前所未有的低事件发生率-无重大中风，无神经系统死亡，无支架血栓形成，长达2年的随访。。

Additionally, Contego Medical is currently evaluating the Neuroguard IEP System with a next-generation direct transcarotid access and protection system, TCAR-IEP, to demonstrate advanced stroke protection regardless of vascular approach in the PERFORMANCE III trial. The Neuroguard IEP Direct system is currently limited by Federal law to investigational use only and is not commercially available in the U.S..

。Neuroguard IEP Direct系统目前受联邦法律限制，仅用于研究用途，在美国不可商购。。

“This strategic agreement marks a significant milestone for both Contego Medical and Medtronic. By combining our innovative product portfolio with Medtronic’s extensive market presence and clinical leadership, we are positioned to revolutionize revascularization treatment in the carotid and peripheral vascular disease space,” said Ravish Sachar, MD, founder and chief executive officer of Contego Medical.

Contego Medical创始人兼首席执行官Ravish Sachar医学博士说：“这项战略协议标志着Contego Medical和美敦力的一个重要里程碑。通过将我们的创新产品组合与美敦力广泛的市场占有率和临床领先地位相结合，我们将彻底改变颈动脉和外周血管疾病领域的血运重建治疗。”。

“This partnership enhances our ability to deliver state-of-the-art solutions to patients and reinforces our commitment to expanding access across the United States.”.

“这种合作关系增强了我们为患者提供最先进解决方案的能力，并加强了我们在美国扩大访问的承诺。”。

Medtronic intends to leverage its Peripheral Vascular and Neurovascular commercial teams to distribute Contego’s portfolio of products in spring 2025.

美敦力计划在2025年春季利用其外围血管和神经血管商业团队分销Contego的产品组合。

About Medtronic

关于美敦力

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

大胆思考。更大胆的行动。。总部位于爱尔兰戈尔韦的美敦力公司是全球领先的医疗保健技术公司，通过寻找和寻找解决方案，大胆应对人类面临的最具挑战性的健康问题。我们的使命是减轻痛苦，恢复健康，延长寿命，我们团结了150多个国家的95000多名充满激情的全球团队。

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

我们的技术和疗法治疗70种健康状况，包括心脏设备、手术机器人、胰岛素泵、手术工具、患者监测系统等。凭借我们丰富的知识、永不满足的好奇心以及帮助所有需要帮助的人的愿望，我们提供了创新技术，每秒钟、每小时、每天都在改变两个人的生活。

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit .

随着我们增强洞察力驱动的护理、以人为本的体验以及为我们的世界带来更好的结果，对我们的期望会更高。在我们所做的每件事中，我们都在创造非凡。有关美敦力的更多信息，请访问。

About Contego Medical, Inc.

关于Contego Medical，Inc。

Contego Medical, Inc. is the leader in developing state-of-the-art solutions that transform complex cases into simplified procedures. The company’s portfolio of integrated, multi-functional products is designed to improve patient outcomes and procedural efficiency in the treatment of carotid and peripheral vascular disease.

Contego Medical，Inc.是开发将复杂病例转化为简化程序的最先进解决方案的领导者。该公司的综合多功能产品组合旨在改善颈动脉和外周血管疾病治疗的患者预后和程序效率。

More than 3,000 patients have been treated with Contego Medical products to date..

迄今为止，已有3000多名患者接受了Contego医疗产品的治疗。。